A randomised sham-controlled study evaluating rTMS analgesic efficacy for postherpetic neuralgia

Area of Science:

• Neurology
• Pain Management
• Neuroscience

Background:

• Postherpetic neuralgia (PHN) is a challenging neuropathic pain condition with limited treatment options.
• Repetitive transcranial magnetic stimulation (rTMS) is an emerging therapy with potential for pain reduction in PHN patients.

Purpose of the Study:

• To evaluate the efficacy of rTMS targeting the motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) for treating PHN.
• To compare the effectiveness of M1 and DLPFC stimulation in alleviating pain and improving sleep disturbances in PHN patients.

Main Methods:

• A double-blind, randomized, sham-controlled study involving 51 PHN patients.
• Participants received 10 daily sessions of 10-Hz rTMS over two weeks, targeting M1, DLPFC, or a sham control.
• Pain was assessed using the Visual Analogue Scale (VAS) at multiple follow-up points up to 3 months.

Main Results:

• M1 rTMS demonstrated superior analgesia compared to sham and DLPFC stimulation from week 2 to week 14.
• Both M1 and DLPFC stimulation significantly improved sleep disturbances from week 4 to week 14.
• Pain reduction following M1 stimulation correlated with improved sleep quality.

Conclusions:

• M1 rTMS is more effective than DLPFC stimulation for treating PHN, providing excellent pain response and long-term analgesia.
• Both M1 and DLPFC rTMS are equally effective in improving sleep quality for PHN patients.
• M1 rTMS represents a promising therapeutic option for managing refractory PHN.